J. Hoekstra

发表

Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production.

J. Romijn, T. Derks, A. Grefhorst, 2005, American journal of physiology. Gastrointestinal and liver physiology.

Long‐term follow‐up of patients with portal vein thrombosis and myeloproliferative neoplasms

F. Leebeek, J. Smalberg, J. Hoekstra, 2011, Journal of thrombosis and haemostasis : JTH.

Vascular liver disorders (II): portal vein thrombosis.

H. Janssen, J. Hoekstra, H. Janssen, 2009, The Netherlands journal of medicine.

Vascular liver disorders (I): diagnosis, treatment and prognosis of Budd-Chiari syndrome.

H. Janssen, J. Hoekstra, 2008, The Netherlands journal of medicine.

Anticoagulant therapy in patients with non‐cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding

H. Janssen, F. Leebeek, B. Hansen, 2013, Journal of thrombosis and haemostasis : JTH.

Pregnancy in women with portal vein thrombosis: results of a multicentric European study on maternal and fetal management and outcome.

D. Thabut, D. Luton, D. Valla, 2012, Journal of hepatology.

Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome.

D. Valla, J. Trebicka, E. Elias, 2010, Blood.

Proteomic analysis reveals that apolipoprotein A1 levels are decreased in patients with Budd-Chiari syndrome.

D. Valla, J. Trebicka, H. Janssen, 2011, Journal of hepatology.

Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study.

C. Chagneau, D. Valla, H. Janssen, 2009, Journal of hepatology.

Etiology and Clinical Outcome of Budd-Chiari Syndrome and Portal Vein Thrombosis

J. Hoekstra, 2010 .

Decision making and outcome of pregnancies in female patients with inflammatory bowel disease: findings from a community-based practice

R. West, F. Bekkering, J. Hoekstra, 2018, European journal of gastroenterology & hepatology.

Good long‐term outcome of Budd‐Chiari syndrome with a step‐wise management

D. Valla, J. Trebicka, E. Elias, 2013, Hepatology.

Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry

C. Ponsioen, M. Visschedijk, A. V. van Bodegraven, 2022, Alimentary pharmacology & therapeutics.

Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry

R. Weersma, C. J. van der Woude, A. V. van Bodegraven, 2020, Alimentary pharmacology & therapeutics.

Gene expression profiling in livers of mice after acute inhibition of beta-oxidation.

F. Gerbens, G. T. te Meerman, A. Gerding, 2007, Genomics.

Abnormal clotting parameters before therapeutic ERCP: do they predict major bleeding?

J. Hoekstra, R. Timmer, R. Breumelhof, 1999, European journal of gastroenterology & hepatology.

Superior effectiveness of tofacitinib compared to vedolizumab in anti-TNF experienced ulcerative colitis patients: a nationwide Dutch Registry study.

M. Lowenberg, D. D. de Jong, G. D'Haens, 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

GI ischemia in patients with portal vein thrombosis: a prospective cohort study.

E. Kuipers, H. Janssen, D. van Noord, 2016, Gastrointestinal endoscopy.

Anticoagulant therapy in patients with non‐cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding

B. Hansen, F. Leebeek, J. Hoekstra, 2013, Journal of thrombosis and haemostasis : JTH.

Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study.

C. Chagneau, D. Valla, H. Janssen, 2009, Journal of hepatology.

P510 GASTROINTESTINAL ISCHEMIA IN PATIENTS WITH ACUTE AND CHRONIC PORTAL VEIN THROMBOSIS

E. Kuipers, H. Janssen, E. Tjwa, 2014 .